InformedDNA statement on U.S. Supreme Court Decision on DNA Patents
Statement from InformedDNA Chief Executive Officer, David P. Nixon
ST. PETERSBURG, Fla., June 13, 2013 /PRNewswire-USNewswire/ — “Today’s Supreme Court ruling is an important win for patients everywhere because this decision supports patient choice. This ruling opens the door for additional companies to provide these services. Ultimately, more patients will have timely, affordable access to these important tests, when they are needed.
“InformedDNA believes that an equally important issue still needs to be addressed – specifically legislation that mandates only qualified genetic specialists should be recommending complex tests such as BRCA. Our point of view is supported by an extensive body of medical literature, clinical guidelines and best practices.
“This ruling is particularly relevant now because the Affordable Care Act requires insurance companies cover 100 percent of the cost of genetic counseling for women at higher risk for breast cancer, including women who are not necessarily appropriate for genetic testing. This ensures all women with elevated risk will benefit from an accurate risk assessment and personalized screening and risk reduction strategies.”
InformedDNA is the largest independent U.S. provider of genetic counseling services, with a team of more than 40 board-certified geneticists and genetic counselors. In addition to direct patient care in most genetics specialties and sub-specialties, the privately-held company consults with employers, health plans, medical centers, ancillary healthcare companies, government agencies and laboratories seeking to better understand genomic health and its implications for their organizations and the healthcare system overall.